CLX-001 (Cytolytix)

N/A

Report date: 2025/06/09 15:15:48
NME

Base Information

Drug NameCLX-001 (Cytolytix)
Drug Alias NameCLX001CLX-001
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionCell membrane permeability enhancers
TargetsNot applicable
Therapy Area/IndicationsTriple Negative Breast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKings College London
China Registration ClassN/A

Develop Information

Active CompaniesCytolytix LtdValirx Plc
Inactive CompaniesN/A
Active IndicationsTriple Negative Breast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A